A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies (CaDAnCe-101)
NCT 05006716 Brief Summary Study consists of two main parts to explore…
Read more arrow_forwardNCT 05006716 Brief Summary Study consists of two main parts to explore…
Read more arrow_forwardNCT 06188520 Brief Summary This study is designed to evaluate AZD8421 alone…
Read more arrow_forwardNCT 06625593 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 06422520 Brief Summary This is a first-in-human, Phase 1a/1b study to…
Read more arrow_forwardNCT 06914128 Brief Summary The study treatment, BAY 3713372, is under development…
Read more arrow_forwardNCT 05984277 Brief Summary The purpose of eVOLVE-Lung02 is to test…
Read more arrow_forwardNCT 05999994 Brief Summary The main purpose of the master is to…
Read more arrow_forwardACTRN 12623001077651 Brief Summary This study aims to assess a new cancer…
Read more arrow_forwardACTRN 12623000108617 Brief Summary This study aims to assess a new cancer…
Read more arrow_forwardACTRN 12622001003763 Brief Summary Elevated lipids called ceramides are associated with poorer…
Read more arrow_forward